Reducing Co/O Band Overlap through Spin State Modulation for Stabilized High Capability of 4.6 V LiCoO2.

High-voltage LiCoO2 (LCO) attracts great interest because of its large specific capacity, but it suffers from oxygen release, structural degradation, and quick capacity drop. These daunting issues root from the inferior thermodynamics and kinetics of the triggered oxygen anion redox (OAR) at high voltages. Herein, a tuned redox mechanism with almost only Co redox is demonstrated by atomically engineered high-spin LCO. The high-spin Co network reduces the Co/O band overlap, eliminates the adverse phase transition of O3 → H1-3, delays the exceeding of the O 2p band over the Fermi level, and suppresses excessive O → Co charge transfer at high voltages. This function intrinsically promotes Co redox and restrains O redox, fundamentally addressing the issues of O2 release and coupled detrimental Co reduction. Moreover, the chemomechanical heterogeneity caused by different kinetics of Co/O redox centers and the inferior rate performance limited by slow O redox kinetics is simultaneously improved owing to the suppression of slow OAR and the excitation of fast Co redox. The modulated LCO delivers ultrahigh rate capacities of 216 mAh g-1 (1C) and 195 mAh g-1(5C), as well as high capacity retentions of 90.4% (@100 cycles) and 86.9% (@500 cycles). This work sheds new light on the design for a wide range of O redox cathodes.

Middle Meningeal Artery Embolization Combined With Endoscopic Treatment for Chronic Subdural Hematoma.

OBJECTIVE: To explore the clinical feasibility of middle meningeal artery (MMA) embolization combined with endoscopic treatment for new or recurrent chronic subdural hematoma (CSDH). METHODS: Twenty patients with CSDH treated in the Binzhou Medical University Hospital from June 2020 to October 2022 were analyzed retrospectively. The clinical information, prognosis, imaging results, and surgical results of the patients were collected and analyzed. The authors first performed MMA embolization, and then endoscopic treatment of CSDH was performed after successful embolization of MMA. Results: All 20 patients with CSDH were successfully treated with MMA embolization combined with endoscope-assisted evacuation. The symptoms of all patients were relieved, no surgical complications occurred, and no rebleeding and recurrence were found in follow-up computed tomography. CONCLUSION: Middle meningeal artery embolization combined with endoscopic treatment of CSDH has a good clinical effect, and it may prevent postoperative recurrence.

Vitamin E Exerts Neuroprotective Effects in Pentylenetetrazole Kindling Epilepsy via Suppression of Ferroptosis.

Epilepsy is one of the most common chronic neurological diseases. There is increasing evidence for ferroptosis playing an important role in the occurrence and development of epilepsy. Vitamin E is a common fat-soluble antioxidant that can regulate ferroptosis. The aim of this study was to investigate the effects of vitamin E on ferroptosis of hippocampal neurons in epileptic rats. Sixty-four male Sprague-Dawley (SD) rats were randomly divided into control, pentylenetetrazol (PTZ; 35 mg/kg), vitamin E (200 mg/kg) + PTZ, and Ferrostatin-1 (Fer-1; 2.5 µmol/kg) + PTZ groups, with drugs administered intraperitoneally 15 times every other day for 29 days. The behavioral manifestations (epileptic score, latency, and number of seizures in 30 min) and EEG changes were observed and recorded. Nissl staining and electrophysiological recording were used to assess neuronal damage and excitability in the hippocampal CA1 region, respectively. The levels of iron, glutathione (GSH), and malondialdehyde (MDA) in the hippocampus were assessed by spectrophotometry. Immunofluorescence staining was used to detect lipoxygenase 15 (15-LOX) expression. Western blot was used to determine glutathione peroxidase 4 (GPX4) and 15-LOX protein levels. Vitamin E treatment was associated with decreased epileptic grade, seizure latency, and number of seizures in the PTZ-kindled epileptic model. Vitamin E treatment also decreased 15-LOX expression, inhibited MDA and iron accumulation, and increased GPX4 and GSH expression. In conclusion, vitamin E can reduce neuronal ferroptosis and seizures by inhibiting 15-LOX expression.

Tuning Co2+ Coordination in Cobalt Layered Double Hydroxide Nanosheets via Fe3+ Doping for Efficient Oxygen Evolution.

Inexpensive and efficient electrocatalysts are crucial for the development and practical application of energy conversion and storage technologies. Layered-double-hydroxide (LDH) materials have attracted much attention due to the special layered structure, but their electrocatalytic activity and stability are still limited. Herein, we propose to tune Co2+ occupancy and coordination in cobalt-based LDH nanosheets via Fe3+ doping for efficient and stable electrocatalysis for oxygen evolution reaction (OER). It is found that Fe doping regulates the occupancy and coordination of Co2+ in CoO4 tetrahedrons and CoO6 octahedrons of Co-LDHs. Through density functional theory calculation, we also clarified that Fe3+ not only modulated the Co2+ coordination but also functioned as an added catalytic active site. LDH nanosheets with a Co/Fe ratio of 5:1 show a low OER overpotential, much better than the commercial IrO2, owing to the modulation of Fe3+ doping on the crystal and electronic structures. After appropriate incorporation of Fe3+, the almost inactive octahedral coordinated Co2+ is significantly activated with a partial deletion of tetrahedral coordinated Co2+, which greatly boosts the overall electrocatalytic activity. This study offers some new insights into tuning the crystal and electronic structures of LDHs by lattice doping to achieve high-efficiency electrocatalysis for OER.

Ibuprofen Exerts Antiepileptic and Neuroprotective Effects in the Rat Model of Pentylenetetrazol-Induced Epilepsy via the COX-2/NLRP3/IL-18 Pathway.

Epilepsy is one of the most common diseases of the central nervous system. Recent studies have shown that a variety of inflammatory mediators play a key role in the pathogenesis of the disease. Ibuprofen (IBP) is a well-known anti-inflammatory agent that reduces the neuroinflammatory response and neuronal damage. In this study, we examined the effect of IBP in a rat model of pentylenetetrazol (PTZ)-induced chronic epilepsy. PTZ injection was given a total of 15 times on alternate days (over a period of 29 days) to induce epilepsy. The effects of IBP were evaluated by behavioral observation, EEG recording, Nissl staining, immunohistochemistry, Western blot analysis, and electrophysiological recording. The results showed that IBP alone affected the expression of cyclooxygenase-2 (COX-2) and neuronal excitability but did not cause epilepsy. IBP reduced seizure scores in the PTZ-treated rats, and it minimized the loss of hippocampal neurons. In addition, IBP decreased the secretion of COX-2, inhibited the activation of the NOD-like receptor 3 inflammasome, and reduced the secretion of the inflammatory cytokine interleukin-18. Furthermore, the results of whole-cell patch-clamp revealed that IBP affected action potential properties, including frequency, latency and duration in epileptic rats, suggesting that it may impact neuronal excitability. These effects of IBP may underlie its antiepileptic and neuroprotective actions.

Effect of Ibuprofen on Autophagy of Astrocytes During Pentylenetetrazol-Induced Epilepsy and its Significance: An Experimental Study.

Epilepsy is a chronic neurological disease. Astrogliosis is an important pathological change in epileptic lesions. Studies have reported that ibuprofen can affect autophagy and/or inhibit cell proliferation in many diseases. This study investigated the effect and significance of ibuprofen on autophagy of astrocytes during pentylenetetrazol (PTZ) induced epilepsy. 60 male Sprague-Dawley (SD) rats were randomly divided into five groups: control group (received normal saline), PTZ group, 3-methyladenine (3-MA) + PTZ group, ibuprofen + PTZ group and 3-MA + ibuprofen + PTZ group. Dose of each agent was 35 mg/kg (PTZ), 10 mg/kg (3-MA) and 30 mg/kg (ibuprofen) and all drugs were administered intraperitoneally 15 times on alternate days (29 days). Human astrocytes were cultured in vitro. Behavioral performance (i.e., latency, grade and duration of seizures) and EEG of rats were observed and recorded. Proliferation of astrocytes was detected by CCK-8 method. Immunofluorescence and Western blot test were used to detect the expression of LC3 and GFAP. Mean number, grade and duration of seizures were markedly reduced in ibuprofen + PTZ group and 3-MA + ibuprofen + PTZ group (P < 0.05). Similarly, peak of EEG waves were markedly reduced in ibuprofen + PTZ group and 3-MA + ibuprofen + PTZ group (P < 0.05). Compared to the control group, the level of LC3 in ibuprofen group was significantly increased in vitro (P < 0.05). While, levels of LC3 were significantly higher and that of GFAP were significantly lower in ibuprofen + PTZ group (P < 0.05) compared to PTZ group in vivo. Ibuprofen reduces the proliferation of astrocytes by increasing autophagy, thus affecting the development of epilepsy. Therefore, ibuprofen may be used as an adjuvant to improve efficacy of treatment in epilepsy.

Enhancing the Catalytic Activity of Co3O4 Nanosheets for Li-O2 Batteries by the Incoporation of Oxygen Vacancy with Hydrazine Hydrate Reduction.

Li-O2 battery attracts great interest because of the high energy density. But the poor kinetics of the oxygen reduction reaction (ORR) and oxygen evolution reaction (OER) have blocked the practical application. Designing the efficient bifunctional cathode catalysts is of great importance for the Li-O2 battery. Tuning the electronic and surface structure of the catalysts plays an important role. Herein, we propose to enhance the catalytic performance of Co3O4 nanosheets for rechargable Li-O2 batteries by hydrazine hydrate-induced oxygen vacancy formation. The hydrazine hydrate reduction not only introduces oxygen vacancies into Co3O4 nanosheets and modulates the electronic structure but also roughens the surface, which all contribute to the enhancement of ORR and OER activity, especially the activity and stability for OER. Li-O2 cells catalyzed by the oxygen defects-enriched Co3O4 ultrathin nanosheets exhibit much better electrochemical performances in terms of the high initial capacity (∼11 000 mAh g-1), the lower overpotential (∼1.1 V), and the longer cycle life (150 cycles@200 mA g-1). This can be largely attributed to the synergy of the enriched oxygen vacancies and the roughened surface of Co3O4 nanosheets, which not only improves the electron and Li+ conductivity but also provides more active sites and reaction spots. The proposed facile strategy may also be applied to modify other oxides based catalysts for Li-O2 batteries or other fields.

Different Effects of Al Substitution for Mn or Fe on the Structure and Electrochemical Properties of Na0.67Mn0.5Fe0.5O2 as a Sodium Ion Battery Cathode Material.

P2-type layered oxides based on the elements Fe and Mn have attracted great interest as sodium ion battery (SIB) cathode materials owing to their inexpensive metal constituents and high specific capacity. However, they suffer from rapid capacity fading and complicated phase transformations. In this study, we modulate the crystal structure and optimize the electrochemical performances of Na0.67Mn0.5Fe0.5O2 by Al doping for Mn or Fe, respectively, and the roles of Al in the enhancement of the rate capability and cycling performance are unraveled. (1) The substitution of Al for Mn or Fe decreases the lattice parameters a and c but enlarges d spacing and lengthens Na-O bonds, which enhances Na+ diffusion and rate capability especially for Na0.67Mn0.5Fe0.47Al0.03O2. (2) Al doping reduces the thickness of TMO2 and strengthens TM-O/O-O bonding. This enhances the layered structure stability and the capacity retention. (3) Al doping mitigates Mn3+ and Jahn-Teller distortion, mitigating the irreversible phase transition. (4) Al doping also alleviates the lattice volume variation and the structure strain. This further improves the stability of the layered structure and the cycling performances particularly in the case of Al doping for Fe. The in-depth insights into the roles of Al substitution might be also useful for designing high-performance cathode materials for SIBs through appropriate lattice doping.

CuO-Coated and Cu2+-doped Co-modified P2-type Na2/3[Ni1/3Mn2/3]O2 for sodium-ion batteries.

Layered P2-type CuO-coated Na2/3[Ni1/3Mn2/3]O2 (NNMO@CuO) with excellent rate capability and cycling performance was investigated as a sodium-ion battery cathode material for the first time. The NNMO@CuO cathode material combines the advantages of CuO coating and Cu2+ doping. Transmission electron microscopy (TEM) images, TEM elemental line scan analysis and ex situ scanning electron microscopy (SEM) images show that CuO has been successfully coated on the particle surface uniformly, and that this CuO layer effectively suppresses the exfoliation of the metal oxide layers and unfavorable side reactions. Furthermore, Cu2+ is also partially incorporated into the host structure, according to the X-ray diffraction (XRD) patterns and refinement results. Although incorporated Cu2+ does not take part in the redox reactions of the battery cell, the refinement results indicate that the d-spacing of the Na+-ion diffusion layer is enlarged due to Cu2+ doping in the crystal structure, which results in better Na+ kinetics. Thus, the CuO-coated cathode material shows prominent cycling performance and rate capability. We believe that this CuO-coating and Cu2+-doping co-modification strategy provides a promising approach to designing advanced cathode materials for sodium-ion batteries.

Facile Synthesis of Near-Infrared Emissive CdS Quantum Dots for Live Cells Imaging.

CdS quantum dots (QDs) have attracted extensive attention owing to their great potential in optoelectronic nanodevices and biosensors. But their poor water solubility and high cytotoxicity restrict their practical application in live cell imaging. In addition, CdS QDs usually emit blue or green fluorescence, which also have some limitations for cell imaging due to the "water window" effect. In this study, we report a novel strategy to directly synthesize water-soluble and low-cytotoxic CdS QDs with near infrared (NIR) fluorescence through confinement into BSA templates with the mediation of L-cysteine (Cys). The obtained CdS QDs emit NIR fluorescence at 730 nm when exited by 468 nm excitation light, and show good water solubility and low cell cytotoxicity, which can be directly used for live RAW cell imaging. In addition, the effects of the type of amino acids for mediations, and the ratio of both Cys/Cd and Cd/BSA on the fluorescence properties of CdS QDs have also been investigated comprehensively. The mediation of L-cysteine plays a critical role on the formation of CdS QDs emitting NIR fluorescence.

Decreasing Li/Ni Disorder and Improving the Electrochemical Performances of Ni-Rich LiNi0.8Co0.1Mn0.1O2 by Ca Doping.

Decreasing Li/Ni disorder has been a challenging problem for layered oxide materials, where disorder seriously restricts their electrochemical performances for lithium-ion batteries (LIBs). Element doping is a great strategy that has been widely used to stabilize the structure of the cathode material of an LIB and improve its electrochemical performance. On the basis of the results of previous studies, we hypothesized that the element of Ca, which has a lower valence state and larger radius compared to Ni2+, would be an ideal doping element to decrease the Li/Ni disorder of LiMO2 materials and enhance their electrochemical performances. A Ni-rich LiNi0.8Mn0.1Co0.1O2 cathode material was selected as the bare material, which usually shows severe Li/Ni disorder and serious capacity attenuation at a high cutoff voltage. So, a series of Ca-doped LiNi0.8(1-x)Co0.1Mn0.1Ca0.8xO2 (x = 0-8%) samples were synthesized by a traditional solid-state method. As hypothesized, neutron diffraction showed that Ca-doped LiNi0.8Co0.1Mn0.1O2 possessed a lower degree of Li/Ni disorder, and potentiostatic intermittent titration results showed a faster diffusion coefficient of Li+ compared with that of LiNi0.8Mn0.1Co0.1O2. The Ca-doped LiNi0.8Mn0.1Co0.1O2 samples exhibited higher discharge capacities and better cycle stabilities and rate capabilities, especially under a high cutoff voltage with 4.5 V. In addition, the problems of polarization and voltage reduction of LiNi0.8Mn0.1Co0.1O2 were also alleviated by doping with Ca. More importantly, we infer that it is crucial to choose an appropriate doping element and our findings will help in the research of other layered oxide materials.

Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan.

The fetal/neonatal hematopoietic system must generate enough blood cells to meet the demands of rapid growth. This unique challenge might underlie the high incidence of thrombocytopenia among preterm neonates. In this study, neonatal platelet production and turnover were investigated in newborn mice. Based on a combination of blood volume expansion and increasing platelet counts, the platelet mass increased sevenfold during the first 2 weeks of murine life, a time during which thrombopoiesis shifted from liver to bone marrow. Studies applying in vivo biotinylation and mathematical modeling showed that newborn and adult mice had similar platelet production rates, but neonatal platelets survived 1 day longer in circulation. This prolonged lifespan fully accounted for the rise in platelet counts observed during the second week of murine postnatal life. A study of pro-apoptotic and anti-apoptotic Bcl-2 family proteins showed that neonatal platelets had higher levels of the anti-apoptotic protein Bcl-2 and were more resistant to apoptosis induced by the Bcl-2/Bcl-xL inhibitor ABT-737 than adult platelets. However, genetic ablation or pharmacologic inhibition of Bcl-2 alone did not shorten neonatal platelet survival or reduce platelet counts in newborn mice, indicating the existence of redundant or alternative mechanisms mediating the prolonged lifespan of neonatal platelets.

New insights into the modification mechanism of Li-rich Li1.2Mn0.6Ni0.2O2 coated by Li2ZrO3.

Lithium-rich Mn-based layered cathode materials have attracted wide attention due to their high specific capacity for lithium-ion batteries. However, some critical issues i.e. poor rate capability and voltage fade have limited their practical applications. Herein, we propose a synchronous lithiation strategy to coat Li-rich Li1.2Mn0.6Ni0.2O2 (LMNO) with a thin layer of Li(+)-conductive Li2ZrO3. The obtained syn-Li2ZrO3@LMNO integrates the advantages of the Li2ZrO3 coating and Zr(4+) doping, and shows a much higher rate capability and cycling stability than those of the counterpart post-Li2ZrO3@LMNO fabricated by a post-coating method. More importantly, the average voltage of syn-Li2ZrO3@LMNO has been enhanced by 0.15 V and the voltage decay has also been mitigated. New insights into the synergetic modification mechanism of the Li2ZrO3 coating and Zr(4+) doping have been proposed. The coating layer of Li(+)-conductive Li2ZrO3 alleviates the surface side reactions, suppresses the transition metal dissolution and enhances the Li-ion conductivity. Meanwhile, the doping and incorporation of Zr(4+) into the host structure accompanied by the Li2ZrO3 coating expands the interplanar spacing and decreases Li/Ni mixing which facilitates Li(+) diffusion. In addition, the integration of the Li2ZrO3 coating and Zr(4+) doping also further enhances the layered structure stability and mitigates the voltage fade during lithiation/delithiation cycles. Moreover, the proposed synchronous lithiation coating route avoids the duplicated high-temperature calcinations and can also be widely used to modify some other cathode materials.

Understanding the effect of an in situ generated and integrated spinel phase on a layered Li-rich cathode material using a non-stoichiometric strategy.

Recently, spinel-layered integrated Li-rich cathode materials have attracted great interest due to the large enhancement of their electrochemical performances. However, the modification mechanism and the effect of the integrated spinel phase on Li-rich layered cathode materials are still not very clear. Herein, we have successfully synthesized the spinel-layered integrated Li-rich cathode material using a facile non-stoichiometric strategy (NS-LNCMO). The rate capability (84 mA h g-1vs. 28 mA h g-1, 10 C), cycling stability (92.4% vs. 80.5%, 0.2 C), low temperature electrochemical capability (96.5 mA h g-1vs. 59 mA h g-1, -20 °C), initial coulomb efficiency (92% vs. 79%) and voltage fading (2.77 V vs. 3.02 V, 200 cycles@1 C) of spinel-layered integrated Li-rich cathode materials have been significantly improved compared with a pure Li-rich phase cathode. Some new insights into the effect of the integrated spinel phase on a layered Li-rich cathode have been proposed through a comparison of the structure evolution of the integrated and Li-rich only materials before and after cycling. The Li-ion diffusion coefficient of NS-LNCMO has been enlarged by about 3 times and almost does not change even after 100 cycles indicating an enhanced structure stability. The integration of the spinel phase not only enhances the structure stability of the layered Li-rich phase during charging-discharging but also expands the interslab spacing of the Li-ion diffusion layer, and elongates TM-O covalent bond lengths, which lowers the activation barrier of Li+-transportation, and alleviates the structure strain during the cycling procedure.

Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay: correlation with pregnancy-associated hormone prolactin.

Hepcidin is a central regulator in human iron metabolism. Although it is often regarded as a promising indicator of iron status, the lack of effective quantification method has impeded the comprehensive assessment of its physiological and clinical significance. Herein we applied a newly established, nanopore film enrichment based hepcidin assay to examine the correlation between hepcidin and prolactin, the hormone with an important role during pregnancy and lactation. Women with pathologically elevated prolactin secretion (hyperprolactinemia) were found to have lower serum hepcidin compared to those with normal prolactin levels, without showing significant difference in other hepcidin-regulating factors. Moreover, prolactin-reducing drug bromocriptine mesylate resulted in elevated expression of the hepcidin in hyperprolactinemia patients. These findings suggest a possible role of prolactin in regulation of hepcidin, and may render hepcidin a useful biomarker for progress monitoring and treatment of iron-related diseases under hyperprolactinemic conditions. FROM THE CLINICAL EDITOR: The level of hepcidin has been shown to reflect the underlying iron status of the patient. Nonentheless, there is an urgent need of reliable, fast and easy-to-do hepcidin assay in the clinical setting. In this paper, the authors described a further modification of their previously described nanopore silica film-based enrichment approach for quantification of hepcidin and found correlation between hepcidin and prolactin. This new knowledge may add to current understanding of iron homeostasis during pregnancy.

A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including asparaginase or its prolonged form.

Asparaginase is essential in the initial management of acute lymphoblastic leukemia (ALL) but frequently leads to venous thromboembolism (VTE). Using anticoagulants for primary VTE prevention has been studied with no consensus. We conducted a systematic literature search in PubMed, Scopus, and Web of science and performed random-effect meta-analysis using Mantel-Haenszel method in RevMan 5.4 to analyze primary pharmacological thromboprophylaxis during asparaginase treatment in early-phase (induction, consolidation, or intensification phase) therapy in patients with ALL with all ages and followed with subgroup analysis by age. Meta-analysis of 13 articles describing the effect of antithrombin supplementation in 1375 patients showed that antithrombin prophylaxis decreases the risk of VTE by 43% (RR, 0.57; 95% CI, 0.38 - 0.83; p=0.004), with mild heterogeneity (I2=35%, p=0.10) and moderate certainty by GRADE. 8 articles included for meta-analysis of low-molecular weight heparin (LMWH) treatment in 612 patients showed that it decreased the risk of VTE by nearly 40% (RR, 0.61; 95% CI, 0.45 - 0.81; p=0.00081), with minimal heterogeneity (I2=14%, p=0.31) but low certainty. Subgroup analysis showed that only prophylaxis with antithrombin supplementation significantly decreased the VTE rate in adult patients with moderate certainty. In pediatric patients, one nonrandomized prospective study showed that LMWH combined with antithrombin has a better thromboprophylaxis effect than antithrombin alone. In the PREVAPIX-ALL trial, prophylaxis with direct factor Xa inhibitor Apixaban did not benefit children younger than 18 years except for cases of obesity. We concluded that thromboprophylaxis with antithrombin is effective in ALL patients older than 18 years during the early phase of therapy, and LMWH combined with antithrombin supplementation might be effective for pediatric patients with ALL. Apixaban is effective in pediatric ALL patients with obesity and needs further study in other high-risk patients.

Regulation of baking quality and starch digestibility in whole wheat bread based on ß-glucans and protein addition strategy: Significance of protein-starch-water interaction in dough.

Whole wheat bread has high nutritional value but is characterized by inferior quality and a high glycemic index. Studies have shown that adding ß-glucans and protein can improve bread quality. This study investigated the effects of added oat ß-glucan, barley ß-glucan, or yeast ß-glucan on protein synergy and whole wheat dough and bread quality. The mixing properties, rheological properties, and scanning electron microscopy observations showed that the addition of ß-glucan promoted the formation of gluten networks, while the synergy between the wheat proteins and ß-glucan resulted in a more robust and stable gluten network and a stronger physical starch envelope. Rapid visco-analysis and thermal property evaluations showed that ß-glucan addition inhibited the thermal degradation, gelatinization, and retrogradation of starch. Based on the bread quality results, it was found the ß-glucan could cause some damage to the bread baking quality. For example, the hardness of samples with oats, barley, and yeast increased to 881.69 g, 952.97 g, and 631.75 g, respectively, compared to samples without ß-glucan (317.49 g), whereas the inclusion of yeast ß-glucan proved to be less detrimental. Protein and ß-glucan both reduced starch digestion to some degree, and showed better synergistic effects, with the lowest estimated glycemic index of 70.08 observed in bread containing added yeast ß-glucan and protein. Therefore, yeast ß-glucan and protein mixtures could be selected as viable formulations for enhancing the quality of whole wheat bread.